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Background. There have been numerous reports of clustered outbreaks of Pneumocystis pneumonia (PCP)
at renal transplant centers over the past 2 decades. It has been unclear whether these outbreaks were linked
epidemiologically to 1 or several unique strains, which could have implications for transmission patterns or strain
virulence.
Methods. Restriction fragment length polymorphism (RFLP) analysis was used to compare Pneumocystis
isolates from 3 outbreaks of PCP in renal transplant patients in Germany, Switzerland, and Japan, as well as
nontransplant isolates from both human immunodeficiency virus (HIV)–infected and uninfected patients.
Results. Based on RFLP analysis, a single Pneumocystis strain caused pneumonia in transplant patients in
Switzerland (7 patients) and Germany (14 patients). This strain was different from the strain that caused an
outbreak in transplant patients in Japan, as well as strains causing sporadic cases of PCP in nontransplant patients
with or without HIV infection.
Conclusions. Two geographically distinct clusters of PCP in Europe were due to a single strain of Pneumocystis.
This suggests either enhanced virulence of this strain in transplant patients or a common, but unidentified, source of
transmission. Outbreaks of PCP can be better understood by enhanced knowledge of transmission patterns and
strain variation.
Pneumocystis jirovecii continues to be an important,
often fatal, cause of Pneumocystis pneumonia (PCP) in
a wide spectrum of immunosuppressed patients in-
cluding patients with human immunodeficiency virus
(HIV) infection and patients who have received human
stem cell or solid organ transplants [1, 2]. Although
prophylaxis has been very effective in preventing PCP
in HIV infection, identification of patients who are at
risk for PCP and thus suitable candidates for pro-
phylaxis in non-HIV populations can be more difficult.
Notable outbreaks of PCP have occurred, especially in
renal transplant patients over the past 2 decades, pri-
marily from centers in Europe and Japan [3–9]. Renal
transplant patients in the recent era may well have
been susceptible to PCP because of inconsistent use of
anti-Pneumocystis prophylaxis at many centers in the
context of changing immunosuppressive regimens.
However, the dramatic occurrence of clusters that are
geographically and temporally distinct suggests that
special circumstances may exist where renal transplant
patients are uniquely susceptible to infection, possibly
due to epidemiologic factors, such as dedicated clinics
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for transplant patients, or to a unique, potentially more vir-
ulent strain of Pneumocystis.
We have recently developed a typing technique using re-
striction fragment length polymorphism (RFLP) analysis that
has allowed us to demonstrate substantial diversity among
Pneumocystis isolates, both in HIV-infected and uninfected
patients [10]. A remarkable feature of our studies is the tre-
mendous variability seen in the RFLP patterns: no 2 patients
with sporadic cases of PCP showed the same pattern, suggesting
that each case was caused by a unique strain of Pneumocystis.
However, in contrast to this experience with sporadic cases,
using this technique we were able to confirm that an outbreak
of PCP in Germany in 2006 was caused by a single Pneumocystis
strain [7, 10]. These studies support the high discriminatory
power of this typing technique. The availability of samples from
additional outbreaks in renal transplant centers in Zurich,
Switzerland (2006–2007) [5], and Nagoya, Japan (2004–2008)
[8], provided an opportunity to study strain differences among
patients and centers and to compare strains causing disease
within Europe with those outside of Europe.
MATERIALS AND METHODS
Patients
The epidemiology, patient characteristics, and molecular anal-
ysis of P. jirovecii isolates using single-nucleotide polymorphism
(SNP) or multilocus sequence typing (MLST) analysis for the
outbreaks of PCP in Munich, Zurich, and Nagoya and RFLP
analysis for the Munich outbreak have been previously reported
[5, 7, 8, 10]. Extracted DNA that included samples from patients
who were identified as being part of the outbreak as well as local
nonoutbreak (control) PCP samples were provided to the
National Institutes of Health (NIH) as coded samples. RFLP
analysis was performed in a blinded manner, and the code
from each center was not broken until the analysis from that
center was complete. Samples from all 11 patients from Zurich
(7 outbreak and 4 control) and all 10 from Nagoya (9 outbreak
and 1 control) that had previously undergone molecular typing
analysis were made available for our studies. To allow confir-
mation of the results for the latter, a second, recoded aliquot
of the same 10 samples was provided and again analyzed in
a blinded manner. Our previous analysis of samples from
Munich included 13 of the 16 outbreak patients who had un-
dergone molecular typing analysis as well as 6 control samples
[10]. The guidelines of the US Department of Health and
Human Services and the NIH were followed in the conduct of
these studies.
Polymerase Chain Reaction Amplification and RFLP Analysis
As a first step, the msg gene copy number for each DNA sample
was quantified by a previously described real-time quantitative
polymerase chain reaction (qPCR) assay [11]. In previous
studies we have shown that for reproducibility, a minimum
of approximately 1000 msg copies needs to be used per
RFLP PCR reaction [10]. Subsequently, msg variable region
(1.3 kb) was amplified by a seminested PCR as previously
described [10], using primers GK 472, GK 452, and GK 195.
A minimum of 1000 msg copies per reaction was used
whenever possible. The PCR was performed using HotStart
Taq DNA polymerase (Qiagen), and the conditions were
15 minutes at 95C followed by 35 cycles of 30 seconds at
94C, 30 seconds at 60C, and 4 minutes (for the first round)
or 2 minutes (for the second round) at 72C, with a final
extension of 10 minutes at 72C.
RFLP analysis was performed as previously described [10].
Agarose gel electrophoresis was used to verify that amplifi-
cation was successful. PCR products were purified using
the QuickStep 2 PCR Purification Kit (Edge BioSystems,
Gaithersburg, Maryland), digested with DraI and Hpy188I
restriction enzymes for 6 hours at 37C, and analyzed on a 1%
or 2% tris-borate-ethylenediaminetetraacetic acid agarose
gel following staining with SYBR green (Molecular Probes,
Eugene, Oregon), as well as by Southern blotting. For the
latter, the blot was hybridized with a digoxigenin-labeled
DNA probe (PCR DIG Probe Synthesis Kit; Roche, Indian-
apolis, Indiana) of 1.3 kb that was an equal mixture of
PCR products from 4 P. jirovecii isolates; hybridization signal
was detected using alkaline phosphatase–conjugated anti-
digoxigenin antibody and CDP-Star (Roche) and a Kodak
Image Station 440CF (PerkinElmer, Waltham, Massachusetts).
Each run included Lambda/HindIII molecular weight markers
or a single clinical sample (sample number 385) as an internal
control.
The gels were analyzed using BioNumerics software version
4.01 (Applied Maths, Austin, Texas) as previously described
[10]. The pattern of banding among different gels/blots was
normalized using Lambda/HindIII molecular weight markers.
The Dice coefficient was used to analyze the similarity of the
patterns of bands with a position tolerance of 1.9% [12].
The unweighted pair group method with average linkages
was used by the BioNumerics software for cluster analysis.
DNA samples with banding patterns with 100% similarity
(Dice coefficient 5 1) were considered to be identical.
Standard deviations of the branches in the cluster were ob-
tained using the BioNumerics ‘‘Clustering/Calculate error
flags’’ setting and represent the reliability and internal consis-
tency of the branch.
26S Ribosomal RNA and Tandem Repeat Analysis
Amplification and sequencing of the 26S ribosomal RNA
(rRNA) gene and tandem repeats in the intron of the msg ex-
pression site were performed as previously described [5, 7, 13, 14].
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RESULTS
Analysis of the Outbreak in Zurich
Our initial goal was to determine whether RFLP analysis could
demonstrate that a single strain of Pneumocystis was re-
sponsible for the outbreak of PCP in Zurich. Two P. jirovecii
DNA samples from a single patient had a very low msg copy
number and could not be amplified for RFLP analysis. Of the
remaining 10 samples (10 patients) analyzed in a blinded
manner, 7 had an identical pattern by RFLP analysis when
digested with either DraI or Hpy1881 restriction enzymes
and evaluated by either agarose gel electrophoresis or
Southern blotting (Figure 1). After breaking the code, these 7
patients were confirmed to be part of the renal transplant
outbreak. The remaining 3 samples had a different pattern
with each enzyme and were confirmed to be from control,
nonoutbreak patients.
Given that the outbreaks in both Munich and Zurich were in
renal transplant patients, we sought to determine whether the
same P. jirovecii strain was responsible for these outbreaks.
Because all 14 previously studied German samples gave an
identical RFLP pattern [7], we included a single representative
German isolate in each gel for the RFLP analysis of the Swiss
isolates. As can be seen in Figure 1, the RFLP pattern for the
German isolate (lane G) was identical to that of the Swiss
outbreak isolates with both restriction enzymes. Thus, the same
P. jirovecii strain was apparently responsible for 2 separate
and geographically distinct outbreaks in renal transplant patients.
In the original reports of the 2 outbreaks, MLST was per-
formed using the same set of 4 gene targets [5, 7]. For 3 of the
4 genes, the same allele was identified in transplant patient
isolates in both centers: alleles B, 7, and 1 for ITS1, mt26S, and
b-tubulin, respectively. For the fourth gene, 26S rRNA, each
center reported identification of a new allele, designated as
allele 4 [7] and allele 5 [5]. To determine if these alleles were
identical, we sequenced 1–2 isolates from each outbreak. We
found that both isolates had an identical sequence that differed
from the reference, allele 1, at positions 301–306: allele 1 had
TACTCT in these positions, while the outbreak isolates had
ACTCTT. Thus, MLST analysis provided further evidence that
the 2 outbreaks were caused by a single strain. Sequencing of
a limited number of subcloned msg genes from Swiss and
German isolates provided additional support that they are the
same strain (data not shown).
We were not able to undertake a formal epidemiologic in-
vestigation and thus do not know if there was any link between
either patients or healthcare providers at the 2 centers.
Analysis of the Outbreak in Nagoya
Given that 2 outbreaks in renal transplant patients in Europe
were caused by a single P. jirovecii strain, we wanted to determine
whether renal transplant patients were uniquely susceptible to
this strain by examining isolates from a third outbreak that
occurred in Nagoya, Japan. We obtained 10 DNA samples
from this outbreak [8], but only 4 could be amplified for
RFLP analysis; the remaining 6 samples had very low (,20)
msg copies/lL. In each experiment we included representative
samples from Switzerland (S) and Germany (G) to compare
the RFLP pattern from different outbreaks.
Three of the 4 amplifiable DNA samples from Japan that were
analyzed in a blinded manner showed an identical RFLP
banding pattern when they were digested with DraI or Hpy188I
(Figure 2). One sample (38 msg copies/lL, 1000 msg copies
per assay) showed a different RFLP pattern both with DraI
and Hpy188I when compared with the other samples. None of
the 4 samples showed an RFLP pattern that was identical to
the Swiss or German pattern (Figure 2). After breaking the
code, all 4 samples were found to be from renal transplant
patients. To verify these results, a second aliquot of all 10
samples (recoded) was sent for RFLP analysis, again in a blin-
ded manner. Only 3 samples could be amplified for RFLP
analysis; all 3 showed an identical pattern to each other and
to the 3 identical samples from the first round. Thus, the
same strain of P. jirovecii appears to be responsible for 3
of these infections in renal transplant patients, but this
strain is different from the strain that caused the 2 European
outbreaks.
Figure 3 shows a dendrogram of samples from the current
study (representative outbreak as well as control samples)
together with samples from endemic cases included in a prior
publication [10]. The cases from the European and Japanese
outbreaks cluster together but separately from each other as
well as from the endemic cases.
To extend our observations we examined 1 representative
German sample and 2 representative Swiss samples from renal
transplant patients using a second typing method based on
variation in the number and sequence of tandem repeats in
the msg expression site [14]. In addition, we were able to
amplify all 10 Japanese samples for this analysis, presumably
because the region being amplified was shorter than that re-
quired for RFLP analysis, which allows a higher amplification
efficiency. All 13 samples had 3 tandem repeats with an
identical sequence. Thus, RFLP analysis provided greater
discrimination than tandem repeat analysis for distinguishing
among the strains. However, although 9 Japanese samples
were identical throughout the sequenced region (250 bp),
the 10th sample, which was from the nontransplant patient
(and which could not be amplified for RFLP analysis), had
2 SNPs outside the tandem repeat region that differed from
the other samples (Figure 4). This is consistent with disease
resulting from infection with a strain different from the pri-
mary outbreak strain in Japan.
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DISCUSSION
RFLP analysis provides an important new tool for studying the
epidemiology of Pneumocystis infection. In general, each case of
sporadic PCP, whether in HIV-infected patients or in other
immunosuppressed patients, is caused by a unique strain of
Pneumocystis as determined based on RFLP analysis. However,
in the current study, we have demonstrated that 2 geographically
Figure 1. Restriction fragment length polymorphism (RFLP) analysis of Pneumocystis samples from Zurich, Switzerland. A–D, The RFLP pattern
following agarose gel electrophoresis for the 10 samples that could be amplified for analysis. Labels at the top represent the individual samples. A and C,
Gels were run following digestion with DraI. B and D, Gels were run following digestion with Hpy188I. Samples 1–6 and 14 are from renal transplant
patients, and samples 7, 10, and 12 are from control patients. The letter G denotes a representative sample from the outbreak in Munich, Germany;1 is
a positive control. With both enzymes, the RFLP patterns of the renal transplant patients are identical to each other and to the German sample, whereas
the control patients showed patterns that were different from each other as well as from the transplant patients. E and F, Southern blots of the gels from
panels A and B, confirming the results of the gel analysis. Molecular weight markers are indicated on the left.
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distinct outbreaks of PCP involving renal transplant recipients
were due to a single, unique Pneumocystis strain that we had not
previously identified in other populations [10]. In line with our
previous observations, the 9 contemporaneous nonoutbreak
isolates (6 from Germany [10] and 3 from Switzerland) all
showed unique RFLP patterns. Thus, although the number of
nonoutbreak isolates studied at each site is small, the outbreaks
caused by the European Renal Transplant (ERT) strain do not
appear to simply represent infection with a predominant,
locally circulating strain. Additional analyses of larger num-
bers of isolates, both from endemic and epidemic cases, as well
as colonized or subclinically infected individuals, will more
definitively answer this question.
MLST analysis further supports these results: we have rec-
onciled the differences originally reported in 26S rRNA alleles
by showing that isolates from both outbreaks had the same
allele. Original sequencing data from the German outbreak
confirmed this as well. Thus, isolates from both outbreaks
have an identical allele in all 4 genes. We were unable to find
any information that epidemiologically linked patients at
the German center and the Swiss center, which are .300 km
apart.
We explored the possibility that this Pneumocystis isolate
might have a unique association with renal transplant recipients
in general, but found that 4 cases in a renal transplant center in
Japan had disease due to a different strain. Thus, the ERT strain
is not the only strain to cause disease in renal transplant recip-
ients. Two outbreaks recently reported from northwest England
also are likely not caused by the same strain, given that they
have different mt26S alleles [15]. Similarly, a 2010 outbreak
reported from Australia also appears to be caused by a dif-
ferent strain based on MLST, although RFLP analysis of these
isolates would be needed to definitively confirm this [16].
Chemoprophylaxis with trimethoprim-sulfamethoxazole or
an alternative agent [17] would likely have prevented a sub-
stantial fraction of these cases. However, due in part to the low
incidence of PCP in the period preceding the outbreaks, none
of the patients in these outbreaks received PCP prophylaxis
(although a subset of patients in 1 study received short courses
of trimethoprim-sulfamethoxazole for urinary tract infection
prophylaxis). Following the institution of routine prophylaxis
at all 3 centers, the incidence of PCP decreased markedly [5, 7, 8].
Guidelines for the management of renal transplant patients
currently incorporate routine anti-PCP prophylaxis [18].
Recently developed typing methods have led to important
advances in our understanding of the epidemiology of Pneu-
mocystis. Many patients appear to be infected with multiple
strains of Pneumocystis simultaneously [14, 19]. Although it
was long thought that PCP represented reactivation of latent
infection that had occurred much earlier in life, possibly during
infancy, recent studies have suggested that many sporadic cases
in HIV-infected patients result from recently acquired infection
[20].
The demonstration that outbreaks of PCP at 1 or more renal
transplant centers were caused by a single strain of Pneumocystis
provides unambiguous evidence that disease can result from
Figure 2. Restriction fragment length polymorphism (RFLP) analysis of Pneumocystis samples from Nagoya, Japan. The RFLP pattern following agarose
gel electrophoresis (A) (following digestion with DraI on the left and Hpy188I on the right) and following Southern blotting (B), for the 4 samples that could
be amplified for analysis. Labels at the top represent the individual samples. All 4 samples (J1, J2, J5, and J8) are from renal transplant patients. The
letter G denotes a representative sample from the outbreak in Munich, Germany; the letter S denotes a representative sample from the outbreak in
Zurich, Switzerland; 1 is a positive control. Samples J1, J2, and J5 showed a pattern identical to each other but different from the G and S samples,
whereas sample J8 was different from all other samples. Molecular weight markers are indicated on the left.
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Figure 3. Dendrogram derived by BioNumerics software from restriction fragment length polymorphism (RFLP) analysis of 53 samples following
agarose gel electrophoresis. All samples were digested with DraI. Thirty-six are samples from endemic cases of Pneumocystis pneumonia that were
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recent infection. The alternative explanation, that all individuals
were infected during infancy with the same Pneumocystis
strain that subsequently reactivated during immunosuppres-
sion, appears highly unlikely given the tremendous strain
diversity we have previously found by RFLP typing [10].
What is the mechanism of transmission of Pneumocystis in
these outbreaks? Animal studies have demonstrated that trans-
mission is via the respiratory route, and Pneumocystis organisms
have been identified in the air near infected patients and animals
[21–23]. Pneumocystis species have a strict host specificity, and
thus human infection does not represent a zoonosis. To date,
there is no convincing evidence for an environmental source
of infection, although such a source cannot be ruled out de-
finitively at present. For all 3 outbreaks included in this study,
the initial reports were able to identify potential contacts
between infected patients [5, 7, 8]. Thus, it seems likely that
the organism was transmitted from other infected patients or
alternatively that a healthcare worker or patient may have been
persistently colonized or had a subclinical infection that al-
lowed transmission to a more susceptible population. The fact
that at least 21 cases in 2 centers in Europe (amplifiable DNA
was unavailable for additional outbreak cases) were due to
a single strain raises the possibility that this strain is unusually
virulent for the renal transplant population, although the oc-
currence of outbreaks caused by apparently different strains
makes this less likely. The outbreaks may result from a combi-
nation of these factors, which are not mutually exclusive.
Whether respiratory isolation of infected patients would
decrease the risk of transmission is unknown, because in an-
imals the incubation time following exposure to development
of severe infection may be 2–3 months [24]. Nonetheless, given
the clear demonstration that infection can be transmitted among
susceptible patients, potentially susceptible patients should not
be exposed to patients with active PCP to minimize the risk
of such transmission. Alternatively, such patients may be pro-
vided with anti-Pneumocystis prophylaxis. However, given the
difficulty in clearly defining risk for Pneumocystis pneumonia in
many non-HIV populations, it does not seem feasible to pro-
vide all such patients with timely prophylaxis.
The link between the 2 European outbreaks is unidentified at
present. Additional studies comparing the strains responsible for
outbreaks in renal transplant patients at other centers both in
Figure 4. Sequence analysis and alignment of a region in the intron of the msg expression site that includes tandem repeats, which are underlined.
Shown are results for 2 Swiss samples (S1, S5), a German sample (G), and 2 Japanese samples (J9, J10). Samples J1–J8 (not shown) were identical in
sequence to sample J9. For comparison are 4 sequences with 2, 3, 4, or 6 tandem repeats (A2–A6) obtained from a single patient from the United States
[14]. Although restriction fragment length polymorphism analysis identified differences between the Japanese and European isolates, in this region the
sequences from all renal transplant patients from the 3 countries were identical. The isolate from a nontransplant Japanese patient (J10) differed from
the transplant isolates at 2 positions indicated by the arrows.
Figure 3 continued. included in a prior publication [10]. Seventeen samples are from the current study and include 4 representative samples from the
outbreaks and the 9 control samples from Switzerland (Sw) and Germany (Ge), as well as the 4 outbreak samples from Japan (Ja). The Dice coefficient
was used to calculate similarities, and unweighted pair group method with average linkages was used for cluster analysis. The position tolerance was
1.9%. The percent similarity scale is shown above the dendrogram and indicated by the numbers at the individual nodes. SDs of the branches are
indicated by the gray bars. For branches without a bar, the SD was 0. The samples from the outbreaks in Europe and Japan form unique clusters that are
boxed. The control samples from Europe and the outbreak sample from Japan that had a different RFLP pattern are indicated by a 1. As previously
reported, 6 of the paired samples with 100% identity represent samples from the same patient collected at different times [10].
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Europe and elsewhere, as well as outbreaks in other suscep-
tible populations, are needed to better define the role that
the ERT strain plays in causing disease in susceptible pop-
ulations. It will be important to determine if this strain has
biological properties that allow it to uniquely infect renal
transplant patients and, if so, to better understand what these
properties are.
Outbreaks of life-threatening disease can have a potentially
devastating impact on immunosuppressed populations. These
outbreaks emphasize the need to develop better parameters
for determining susceptibility to PCP so that prophylaxis can
be continued during periods of enhanced susceptibility. These
outbreaks also emphasize the importance of expanding our
knowledge of biological factors that might enhance organism
virulence and transmission factors that might increase the risk
that susceptible patients will develop disease.
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